TENAX THERAPEUTICS INC (TENX) Stock Income Statement
NASDAQ:TENX - Nasdaq - US88032L6056 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Cost Of Goods | N/A | N/A | N/A | N/A | N/A | |||
| Gross Profit | N/A | N/A | N/A | N/A | N/A | |||
| Operating Expenses | 19.49M | 8.23M | 11.05M | 32.73M | 9.87M | |||
| Research and Development | 12.71M | 3.23M | 5.38M | 25.15M | 4.56M | |||
| Selling, General, and Administrative Expenses | 6.79M | 5.01M | 5.68M | 7.58M | 5.31M | |||
| Operating Income | -19.49M | -8.23M | -11.05M | -32.73M | -9.87M | |||
| Interest Income/Expense | 1.89M | -24.00K | -4.40K | -1.00K | -1.60K | |||
| Other Income/Expense | 1.00K | 547.20K | 9.20K | -254.80K | 18.20K | |||
| Non Recurring Items | N/A | N/A | N/A | 0.00 | N/A | |||
| Income Before Taxes | -17.60M | -7.71M | -11.05M | -32.98M | -9.85M | |||
| Income Tax | 0.00 | N/A | N/A | N/A | N/A | |||
| Net Income | -17.60M | -7.71M | -11.05M | -32.98M | -9.85M | |||
| EBITDA | N/A | -8.23M | -11.05M | -32.72M | -9.86M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.15 | -31.04 | -600.42 | -2.56K | -2.14K | |||
| Non GAAP EPS | -5.32 | -35.38 | N/A | -3.09K | -2.22K | |||
| Statistics | ||||||||
All data in USD